Literature DB >> 7778052

An overview of tick-borne relapsing fever with emphasis on outbreaks in Texas.

J A Rawlings1.   

Abstract

Tick-borne relapsing fever (TBRF), a disease of humans and other animals, has been recognized in North America since early in this century. Caused by Borrelia spirochetes, TBRF is transmitted by softshelled Ornithodoros ticks, which may also act as reservoirs for the etiologic agents. Initial symptoms include sudden onset of fever, chills, headache, arthralgias, and myalgias. Persons with TBRF may suffer several febrile episodes or relapses unless they are diagnosed and treated promptly because TBRF spirochetes are able to alter their outer surface proteins and, thus, escape the infected host's immune response. Laboratory diagnosis is made by detecting spirochetes in peripheral blood specimens or by inoculating laboratory mice with blood collected during febrile episodes. In the 1930s and '40s, TBRF was reported commonly in Texas. More recently, fewer cases have been reported, although 13 cases were confirmed between 1990 and the first half of 1994.

Entities:  

Mesh:

Year:  1995        PMID: 7778052

Source DB:  PubMed          Journal:  Tex Med        ISSN: 0040-4470


  21 in total

1.  Evaluating the risk of tick-borne relapsing fever among occupational cavers-Austin, TX, 2017.

Authors:  Stefanie B Campbell; Anna Klioueva; Jeff Taylor; Christina Nelson; Suzanne Tomasi; Adam Replogle; Natalie Kwit; Christopher Sexton; Amy Schwartz; Alison Hinckley
Journal:  Zoonoses Public Health       Date:  2019-05-31       Impact factor: 2.702

2.  Phylogenetic analysis of the spirochetes Borrelia parkeri and Borrelia turicatae and the potential for tick-borne relapsing fever in Florida.

Authors:  Tom G Schwan; Sandra J Raffel; Merry E Schrumpf; Paul F Policastro; Julie A Rawlings; Robert S Lane; Edward B Breitschwerdt; Stephen F Porcella
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

3.  A novel surface antigen of relapsing fever spirochetes can discriminate between relapsing fever and Lyme borreliosis.

Authors:  Job E Lopez; Merry E Schrumpf; Vijayaraj Nagarajan; Sandra J Raffel; Brandi N McCoy; Tom G Schwan
Journal:  Clin Vaccine Immunol       Date:  2010-02-10

4.  Molecular characterization of the interaction of Borrelia parkeri and Borrelia turicatae with human complement regulators.

Authors:  Melanie Schott; Sonja Grosskinsky; Christiane Brenner; Peter Kraiczy; Reinhard Wallich
Journal:  Infect Immun       Date:  2010-03-15       Impact factor: 3.441

5.  First isolation of the relapsing fever spirochete, Borrelia hermsii, from a domestic dog.

Authors:  Ashley L Kelly; Sandra J Raffel; Robert J Fischer; Michael Bellinghausen; Connie Stevenson; Tom G Schwan
Journal:  Ticks Tick Borne Dis       Date:  2013-11-16       Impact factor: 3.744

6.  Serodiagnosis of Louse-Borne relapsing fever with glycerophosphodiester phosphodiesterase (GlpQ) from Borrelia recurrentis.

Authors:  S F Porcella; S J Raffel; M E Schrumpf; M E Schriefer; D T Dennis; T G Schwan
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

Review 7.  Tick-borne relapsing fever.

Authors:  Mark S Dworkin; Tom G Schwan; Donald E Anderson; Stephanie M Borchardt
Journal:  Infect Dis Clin North Am       Date:  2008-09       Impact factor: 5.982

8.  Mapping the ligand-binding region of Borrelia hermsii fibronectin-binding protein.

Authors:  Christiane Brenner; Katharina Bomans; Jüri Habicht; Markus M Simon; Reinhard Wallich
Journal:  PLoS One       Date:  2013-05-02       Impact factor: 3.240

9.  Tickborne relapsing fever in Israel.

Authors:  Gil Sidi; Nadav Davidovitch; Ran D Balicer; Emilia Anis; Itamar Grotto; Eli Schwartz
Journal:  Emerg Infect Dis       Date:  2005-11       Impact factor: 6.883

10.  Sequence analysis and serological responses against Borrelia turicatae BipA, a putative species-specific antigen.

Authors:  Job E Lopez; Hannah K Wilder; William Boyle; L Brock Drumheller; Justin A Thornton; Bridget Willeford; Timothy W Morgan; Andrea Varela-Stokes
Journal:  PLoS Negl Trop Dis       Date:  2013-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.